Heart failure & cardiomyopathies

Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in Heart Failure with Preserved Ejection Fraction (HFpEF) and HFmrEF: Insights From REDUCE LAP-HF II

JACC Heart FailPublished Secondary analysis of the REDUCE LAP-HF II randomised trial

Authors' conclusion

Longer duration of HFpEF diagnosis is associated with more advanced cardiac remodeling and dysfunction and higher risk of worsening HF

Study context

Population
Patients with heart failure (HF), LVEF ≥40% and exercise pulmonary capillary wedge pressure ≥25 mm Hg
Participants
626 patients
Comparison
HF duration >3 years vs 1-3 years vs <1 year

Primary result

As reported in the abstract

Cardiac structure/function and hemodynamics by HF duration

Biatrial myopathy

Resting PCWP elevation

Outcome>3 years1-3 years<1 year
LV global longitudinal strain, median (Q1-Q3)16.4% [Q1-Q3: 14.3%-18.6%]17.7% [Q1-Q3: 15.4%-20.0%]18.4% [Q1-Q3: 16.3%-20.5%]
RV free wall strain, median (Q1-Q3)20.8% [Q1-Q3: 16.7%-24.6%]22.2% [Q1-Q3: 17.6%-26.1%]24.4% [Q1-Q3: 19.2%-27.2%]

Further findings

OutcomeHR (95% CI)P value
HF event risk1.70 (1.17–2.48)P = 0.006

Atrial shunt response across duration groups

No significant heterogeneity in atrial shunt response across duration groups

Original publication

Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II. JACC Heart Fail. Published 5 June 2026. doi:10.1016/j.jchf.2026.103167

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.